SiBone (NASDAQ:SIBN) vs. Sintx Technologies (NASDAQ:SINT) Critical Analysis

Sintx Technologies (NASDAQ:SINTGet Free Report) and SiBone (NASDAQ:SIBNGet Free Report) are both healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, profitability, risk, earnings, institutional ownership, analyst recommendations and dividends.

Insider & Institutional Ownership

18.4% of Sintx Technologies shares are held by institutional investors. Comparatively, 98.1% of SiBone shares are held by institutional investors. 4.1% of Sintx Technologies shares are held by insiders. Comparatively, 4.0% of SiBone shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Volatility and Risk

Sintx Technologies has a beta of 0.62, indicating that its share price is 38% less volatile than the S&P 500. Comparatively, SiBone has a beta of 0.66, indicating that its share price is 34% less volatile than the S&P 500.

Earnings & Valuation

This table compares Sintx Technologies and SiBone”s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Sintx Technologies $1.02 million 6.48 -$10.36 million ($4.91) -0.31
SiBone $200.93 million 4.30 -$18.90 million ($0.34) -57.26

Sintx Technologies has higher earnings, but lower revenue than SiBone. SiBone is trading at a lower price-to-earnings ratio than Sintx Technologies, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Sintx Technologies and SiBone’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Sintx Technologies -848.20% -354.44% -115.37%
SiBone -6.85% -8.23% -6.07%

Analyst Recommendations

This is a summary of recent ratings and target prices for Sintx Technologies and SiBone, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sintx Technologies 1 0 3 0 2.50
SiBone 1 0 6 0 2.71

Sintx Technologies presently has a consensus price target of $9.33, indicating a potential upside of 510.02%. SiBone has a consensus price target of $24.17, indicating a potential upside of 24.12%. Given Sintx Technologies’ higher possible upside, analysts clearly believe Sintx Technologies is more favorable than SiBone.

Summary

SiBone beats Sintx Technologies on 9 of the 14 factors compared between the two stocks.

About Sintx Technologies

(Get Free Report)

Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. It provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyetheretherketone, and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.

About SiBone

(Get Free Report)

SI-BONE, Inc., a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. It markets its products primarily with a direct sales force, as well as through agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.

Receive News & Ratings for Sintx Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sintx Technologies and related companies with MarketBeat.com's FREE daily email newsletter.